and other foreign compounds are eliminated from the circulation entirely or in part by excretion into the bile (4, 30, 35, 36) . Many of these same compounds are first metabolized and/or conjugated by the liver, with glucuronide conjugation usually the most important in biliary excretion (35).
There have been numerous studies on the effects of drugs as inducers of the hepatic microsomal drug-metabolizing enzymes and these have been currently reviewed (8). However, relatively few reports have appeared on the effects of these enzyme inducers on the hepatic excretory pathways. Schellhas et al. (31) have reported that phenobarbitaltreated rats excreted twice as much sulfobromophthalein (BSP) in the bile as did controls, and this effect was correlated with a marked enhancement of BSP conjugation in vitro. Fujimoto et al. (10) observed more rapid disappearance of BSP from plasma in mice pretreated with phenobarbital. The enhanced plasma clearance was reversed by simultaneous administration of ethionine suggesting that adaptive effects on the conjugating enzyme were involved in the enhanced clearance. Roberts and Plaa (29) demonstrated a significantly enhanced disappearance of bilirubin from plasma of phenobarbital-treated mice, and an increase in the maximal rate of bilirubin excretion in rats. However, in the induced rats there was no change in bilirubin concentration in the bile, due to a concomitant increase in bile volume. Thus, the increase in bilirubin excretion appeared to be related primarily to the increase in bile volume although increases in uptake and conjugating capacity might also have been involved.
The purpose of the present report was to investigate the effects of phenobarbital pretreatment on the hepatic excretory patterns of four foreign organic acids or anions which are known to be actively transported into the bile. Both bilirubin and BSP are organic anions, as are the principal endogenous components of bile, the bile acids (7, 36) . Two of the acids in the present study, chlorothiazide (15) and indocyanine green (ICG) (6), are taken up and excreted by the liver in rats as the unchanged compound. The other two compounds, phenolsulfonphthalein (phenol red) and probenecid, are extensively conjugated to glucuronides prior to excretion into the bile (13, 16). It has been reported that barbiturate pretreatment increases both the hepatic glucuronide conjugation of bilirubin in mice and rats (5, 9), and the glucuronylating activity for p-nitrophenol in rats (42)
Ai a second phase of this project the hepatic excretory patterns in female rats were compared with those of males. Among the usual laboratory species, rats most characteristically exhibit marked sex differences in hepatic drug metabolism (I 1).
METHODS
Male Sprague-Dawley rats (NIH Colony), weighing 250-350 g, and females, weighing 220-275 g, were used and were maintained on laboratory chow and tap water. Phenobarbital sodium, 40 mg/kg, was injected intraperitoneally twice daily for 3 days. Control animals received identical volumes of saline (2 ml/kg).
A nimals were used about 18 hr after the final injection.
Rats were anesthetized with barbital, 250 mg/kg, followed in 15-30 min by pentobarbital 30-45 mg/kg; both drugs were given intraperitoneally. Through a midline incision, the renal pedicles were ligated and the common bile duct was cannulated with a short-beveled 23-gauge hypodermic needle shaft attached to 10 inches of polyethylene tubing. Unless otherwise indicated, bile was collected for 30 min prior to drug administration, followed by three 30-min collection periods. Animals were kept under a warming lamp for the duration of the experiment, and it was observed that the presence of such a lamp prevented any significant decreases in bile flow. A blood sample was then drawn by cardiac puncture and the liver was excised, blotted free of blood, and weighed. Drugs were dissolved in water or saline and were administered intravenously (femoral vein). Indocyanine green in plasma and bile was diluted with water and assayed by measuring its absorption at 805 rnp as described by Wheeler et al. (39) . Hepatic content of ICG was estimated as follows: Liver was homogenized with a volume, in milliliters, of distilled water equal to the wet weight, in grams, of the liver. To 1 ml of the resulting 50 % homogenate in a 13-ml stoppered centrifuge tube 9 ml absolute methanol were added. The contents were mixed well by inversion and the tubes were centrifuged 15 min at 4 C. 
RESULTS
Indocyanine green excretion. It can be seen in Table  1 that there was a significant increase (P < O*Ol) of about 60 % over control in total 90-min biliary excretion by male rats pretreated with phenobarbital for 3 days (65 vs. 41 %). Likewise, the pattern of excretion differed between phenobarbital-treated and control animals in that peak biliary excretion occurred during the first 30-min period for the former, while in the controls absolute excretion rose and fell more gradually over the course of the experimental period. A possible explanation for the increased biliary clearance of ICG may be provided by the effects of phenobarbital on bile flow as also seen in Table 1 . There was a significantly greater (P < 0.01) average bile flow in the phenobarbitaltreated animals at all time periods.
(Bile flow rates were about 50 % greater (significant at P < 0.05) in all phenobarbital-pretreated rats, male and female, with the singIe exception of some time periods of the female rats which received ICG (Table 1) ; such differences may be cited in the text, but are actually enumerated only in Tables 1 and 9 .) The bile Aow was greater even before ICG was injected. Calculation of the average percent increase in bile flow produced by phenobarbital gives a range of from 52 to 60 % for the three 30-min time periods and this increase corresponds with the overall increase over control excretion of ICG. Roberts and Plaa (29) observed parallel increases in bile flow and maximal excretion of bilirubin after phenobarbital pretreatment.
Moreover, in their experiments there were no significant differences in bile bilirubin concentrations.
It should be noted, that the single injections of ICG which were used in our experiments
were not Tm doses, while Roberts and Plaa (29) employed a constant infusion of bilirubin at a Tm dose. In the present report the average bile concentration was higher during the first 30 min in the phenobarbital-treated group (133 vs. 93 pg/ml; P < 0.05) with the reverse being true during the 30-to 60-min period (100 vs. 119 pg/ml; P > 0.5) and 60-to 90-min period (51 vs. 78 pg/ml; P < 0.05). (B 1 i e concentrations (pg/ml) of the various drugs studied are cited in the text where deemed necessary but to conserve space are not listed among the tabular data.) These trends in the biliary excretion profile may be misleading if it is not understood that in the phenobarbital-treated animals the greatest portion of the ICG dose was excreted during the 0-to 30-min period. Hence, when given at this dose, the excretion of ICG during the next two 30-min periods may have fallen off because the load presented to the liver was decreasing. Table 2 it also can be observed that phenobarbital treatment of female rats resulted in nearly a twofold increase over controls in both absolute excretion of chlorothiazide at each 30-min interval and in total percent of the dose excreted in 90 min. Excretion of the drug was also significantly less in the control female than in either control or phenobarbital-treated male rats. In the female rats treated with phenobarbital the greater excretion appeared to be related directly to increased bile flow, about 50 % above control, since there were no significant differences in biliary concentration of chlorothiazide. Phenol red excretion. These experiments failed to indicate any significant effects of phenobarbital on either total biliary excretion or excretion of phenol red as its glucuronide in male rats (Table 3 ). The percent of the injected dose excreted as conjugate in the phenobarbital-treated rats was somewhat lessduringthe 30-to 60-and 60-to 90-min periods than in the controls, although these differences were not significant.
At all times, the bile concentrations (pg/ml) were considerably lower in the phenobarbital-treated animals. The effects of phenobarbital on the biliary excretion of phenol red and its glucuronide in females can be seen in Table 4m The percent of the dose excreted as the parent compound was significantly greater for the controls in both the 30-to 60-and60-to 90-min periods. Neither the total amount of the dose excreted nor the proportion excreted as the glucuronide was altered by phenobarbital treatment. There were, however, significant differences between the sexes with regard to the percent of the dose excreted as the conjugate (Table  5) . Phenobarbital-treated and control female rats excreted only about 55 % as much as the glucuronide as did the males. of ICG, but rather enhanced it since 68 % of the dose of ICG was excreted in 90 min vs. 48 % excreted in the salinetreated controls. An explanation for these paradoxical results may be provided by the data on bile flow rates (Table  8) . At the dose used, chlorothiazide produced a marked increase in bile flow which lasted throughout the experimental period. This choleretic effect of the drug has been reported (15). It is of interest to compare Table 8 with  Table  1 wherein it can be noted that the effects seen on total ICG excretion, on the pattern of ICG excretion, and on the magnitude of increase in bile flow were very similar. It might be reasonably concluded from these parallel effects bile volume, rather than to an increase in metabolism. There did not appear to be any detectable sex differences in the Dattern of excretion for probenecid and its metabolite were comparable to the same parameters in males. As in males, the excretion of glucuronide conjugate as a percentage of the total radioactivity excreted in the bile was not altered by phenobarbital pretreatment. Comparing  Table  6 with Table 7 , there does seem to be a more pronounced effect of phenobarbital in female rats on the percentage of the dose of probenecid excreted, particularly during the 30-to 60-and 60-to 90-min periods. Concentrations of total drug in bile were not different at any time period, 9 . Effects of phenobarbital on plasma disappearance, heputic concentration, and bile excretion of indocyunine green at early times after administration to mule ruts of phenobarbital pretreatment and chlorothiazide administration that the enhanced excretion of ICG in both cases was due largely to the increases in bile volume. Attempts to study the reverse effect, i.e., prior administration of ICG on chlorothiazide excretion, were inconclusive due to the large blanks in bile and plasma from the intense color of ICG.
Efects of phenobarbital treatment on @mu disa~~earunce, hepatic uptake, and bile excretion of indocyanine green at early times after injection. In an attempt to further elucidate the mechanism of action of phenobarbital on ICG excretion, different groups of rats were injected with ICG as before, bile samples were collected for 5, 10, 15, and 30 min, and animals were sacrificed at the end of each of these times and liver and plasma samples were removed for assay as described in
METHODS.
Analysis of the data in Table 9 shows sharp differences at the early times (5, 10, 15 min) in the parameters examined and little difference between treated and controls by 30 min after ICG administration.
After 10 min, in the phenobarbital-treated rats, total bile excretion was 2 to 2.5fold greater, plasma levels were lower, and bile-toplasma concentration ratios were correspondingly greater. Conversely, liver levels (pg/g) were about 33 % lower in the phenobarbital-treated animals at 5, 10, and 15 min. These results suggest that the phenobarbital effect is exerted primarily on the excretory phase although a somewhat more rapid uptake and/or plasma disappearance may also be in .volved. The decrease in hepatic concentration militates against a possible enhancement of storage by phenobarbi tal. Klaassen and Plaa (22) (18) showed that in vitro glucuronyl transferase activity for O-aminophenol glucuronidation was about 4 times as great in liver microsomes from adult male rats as in microsomes from females. On the other hand, transferase activity in females was much more responsive to benzpyrene induction, with increases in activity of more than 250 % occurring after benzpyrene compared with only a 40 % increase in males. In our experiments, the percent of the dose of phenol red in females that was excreted as the glucuronide was only, 50-60 % that in males, but phenobarbital pretreatment was ineffective in either sex in increasing the proportion excreted as conjugate. There were no differences between the sexes for excretion of probenecid. Most of the cited references on the effects of inducers on glucuronyl transferases have been in vitro studies and not directly comparable with the present in vivo results. Recently, however, Goldstein and Taurog (12) reported markedly enhanced biliary excretion of thyroxine in both female and male rats after a single pretreatment with 3,4-benzpyrene.
There was no increase in bile flow and their data indicated that the increases in excretion were due to increases in hepatic glucuronyl transferase activity. These authors observed smaller increases in thyroxine excretion in both sexes after phenobarbital pretreatment which could be accounted for by increased bile flow. Analogous to our studies with probenecid, they found no increases in the proportion of the biliary thyroxine present as glucuronides in phenobarbital-treated animals. Indocyanine green and chlorothiazide are not metabolized prior to their biliary excretion. Thus, the enhanced excretion of ICG in males and of chlorothiazide in females must have been mediated by an effect of phenobarbital other than its acceleration of hepatic drug metabolism. It has been established that phenobarbital does not cause increased biliary uptake or excretion by displacement from plasma protein binding sites (3, 29) . As suggested by Plaa and co-workers (22,29), increases in biliary excretion seem to be due primarily to increases in bile Aow, which we also consistently observed in both sexes after phenobarbital.
Phenobarbital is well known to cause an increase in liver weight (8). In our studies, we observed about a 25 % increase in weight which is similar to increases observed by others, and appears to be a parenchymal hypertrophy and not a hyperplasia (2) . The proposed mechanism of bile formation might be examined in relation to the phenobarbital-induced choleresis and hepatocellular hypertrophy. It has been proposed that the primary event in the formation of bile is the active transport of bile acid anions from parenchymal cells into the bile canaliculi (36). The osmotic effect of these substances results in a passive flow of water and solutes into the canaliculi. Virtually all the bile acids excreted into mammalian bile are first conjugated with taurine and glycine, with taurine predominating in rat bile (17). The bile acids appear to be derived almost entirely from the metabolism of cholesterol. In the rat, Siperstein and Chaikoff (33) and Siperstein et al. (34) demonstrated that 80-90 % of the body cholesterol was converted to bile acids which were then excreted into bile as conjugates.
Recently, Jones and Armstrong (19) and Wada et al. (38) have shown that phenobarbital pretreatment produced 4-to 5-fold increases in cholesterol synthesis from acetate or mevalonate.
Jones and Armstrong (19) did not find an increased accumulation of cholesterol in either liver or plasma, suggesting perhaps that the formed compound was rapidly metabolized and/or excreted. Thus, it seems reasonable to propose that the large increase in bile flow seen after phenobarbital is due primarily to an increased formation and excretion of taurocholate and other bile acids. If true, this effect could be termed an cLendogenous" choleresis in that the choleretic solute is formed in situ. Direct evidence for such a mechanism is lacking at present. Furthermore, it is not known whether the rate-limiting step lies in the conversion of cholesterol to bile acids or in the enzyme conjugation of the latter with taurine or glycine. With reference to bile pigment excretion, a twofold increase in bile bilirubin excretion has been reported after phenobarbital treatment (32). The parallel enhancing effects on ICG excretion of both phenobarbital (Table  1) and chlorothiazide (Table  8 ) are in agreement with Sperber's contention (36) that factors which augment bile flow (i*e., choleretic agents) exert their effects in the same manner as those initiating bile formation.
